Premium
The contextual role of TNFR family members in CD 8 + T‐cell control of viral infections
Author(s) -
Wortzman Michael E.,
Clouthier Derek L.,
McPherson Ann J.,
Lin Gloria H. Y.,
Watts Tania H.
Publication year - 2013
Publication title -
immunological reviews
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.839
H-Index - 223
eISSN - 1600-065X
pISSN - 0105-2896
DOI - 10.1111/imr.12086
Subject(s) - immunology , immune system , biology , tumor necrosis factor alpha , immunity , immunotherapy , antibody , t cell , virology
Summary Immunity to viruses must be tightly controlled to avoid pathology. Receptors and ligands of the tumor necrosis factor ( TNF ) family play important roles in controlling lymphocyte activation and survival during an immune response. The role of specific TNF receptor ( TNFR ) family members in antiviral immunity depends on the stage of the immune response and can vary with the virus type and its virulence. Here, we focus on five members of the TNFR family that are prominently expressed on CD 8 + T cells during viral infections, namely, 4‐1 BB ( CD 137), CD 27, OX 40 ( CD 134), GITR , and TNFR 2. 4‐1 BB , CD 27, OX 40, and GITR have primarily prosurvival roles for CD 8 + T cells during viral infection, although under some circumstances 4‐1 BB , GITR , or CD 27 signals can limit immunity. Although TNFR 2 can be costimulatory under some circumstances, its main role in CD 8 + T‐cell responses during viral infection appears to be in contraction of the response. Several TNF family ligands are being explored as adjuvants for viral vaccines, and agonistic antibodies to TNFR family members are being investigated for immunotherapy of chronic viral infection alone and in combination with checkpoint blockade. Such therapies will require thorough and specific optimization to avoid pathology induced by hyperstimulation of these pathways.